Latest Issue of Science News


News

Hormone therapy falls out of favor

Pills containing estrogen and progestin have been given to provide women protection against heart disease, as well as respite from hot flashes and other symptoms of menopause. Several studies now indicate no heart benefit and increased risks of circulatory disorders and breast and ovarian cancer, several studies indicate.

Scientists who analyzed data on 16,608 postmenopausal women in a nationwide study report in the July 17 Journal of the American Medical Association (JAMA) that women taking the dual-hormone therapy for 5 years had 26 percent more cases of breast cancer than women receiving an inert pill did. Moreover, compared with the placebo, the hormones doubled the incidence of blood clots, hiked stroke incidence by 41 percent, and upped the occurrence of heart disease by 29 percent.

Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.

X
This article is available only to subscribing members. Join SSP today or Log in.